UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 201

Sortiert nach

Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines

Nature communications, 2022-02, Vol.13 (1), p.903-903, Article 903

2022

Volltextzugriff (PDF)

Anti-tau single domain antibodies clear pathological tau and attenuate its toxicity and related functional defects

Cell death & disease, 2024-07, Vol.15 (7), p.543-14, Article 543

2024

Volltextzugriff (PDF)

Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains

Nature communications, 2024-05, Vol.15 (1), p.4301-4301, Article 4301

2024

Volltextzugriff (PDF)

Single-domain antibody-based protein degrader for synucleinopathies

Molecular neurodegeneration, 2024-05, Vol.19 (1), p.44-24, Article 44

2024

Volltextzugriff (PDF)

Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals

Virology (New York, N.Y.), 2012-06, Vol.427 (2), p.198-207

2012

Volltextzugriff (PDF)

Structural Comparison of Human Anti-HIV-1 gp120 V3 Monoclonal Antibodies of the Same Gene Usage Induced by Vaccination and Chronic Infection

Journal of virology, 2018-09, Vol.92 (18)

2018

Volltextzugriff (PDF)

Single domain antibodies targeting pathological tau protein: Influence of four IgG subclasses on efficacy and toxicity

EBioMedicine, 2022-10, Vol.84, p.104249, Article 104249

2022

Volltextzugriff (PDF)

Rabbit Anti-HIV-1 Monoclonal Antibodies Raised by Immunization Can Mimic the Antigen-Binding Modes of Antibodies Derived from HIV-1-Infected Humans

Journal of Virology, 2013-09, Vol.87 (18), p.10221-10231

2013

Volltextzugriff (PDF)

Contrasting antibody responses to intrasubtype superinfection with CRF02_AG

PloS one, 2017-03, Vol.12 (3), p.e0173705-e0173705

2017

Volltextzugriff (PDF)

Elicitation of broadly reactive antibodies against glycan-modulated neutralizing V3 epitopes of HIV-1 by immune complex vaccines

Vaccine, 2013-11, Vol.31 (46), p.5413-5421

2013

Volltextzugriff (PDF)

Efficient Huber-Markov Edge-Preserving Image Restoration

IEEE transactions on image processing, 2006-12, Vol.15 (12), p.3728-3735

2006

Volltextzugriff (PDF)

Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth

PLoS pathogens, 2013-02, Vol.9 (2), p.e1003173-e1003173

2013

Volltextzugriff (PDF)

Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies

PloS one, 2015-10, Vol.10 (10), p.e0141233-e0141233

2015

Volltextzugriff (PDF)

The inhibition effect of anti-GPIIIa49-66 antibody on megakaryocyte differentiation

Thrombosis and haemostasis, 2011-09, Vol.106 (3), p.484

2011

Volltextzugriff (PDF)

The structural features that distinguish PD-L2 from PD-L1 emerged in placental mammals

The Journal of biological chemistry, 2020-04, Vol.295 (14), p.4372-4380

2020

Volltextzugriff (PDF)

The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel

Journal of virology, 2015-08, Vol.89 (15), p.8003-8010

2015

Volltextzugriff (PDF)

Single domain antibody‐based non‐invasive in vivo imaging of tau pathology

Alzheimer's & dementia, 2022-12, Vol.18 (S6), p.n/a

2022

Volltextzugriff (PDF)

VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA

Cell host & microbe, 2020-06, Vol.27 (6), p.963-975.e5

2020

Volltextzugriff (PDF)

Increased Epitope Complexity Correlated with Antibody Affinity Maturation and a Novel Binding Mode Revealed by Structures of Rabbit Antibodies against the Third Variable Loop (V3) of HIV-1 gp120

Journal of virology, 2018-04, Vol.92 (7)

2018

Volltextzugriff (PDF)

Single-domain antibody-based noninvasive in vivo imaging of α-synuclein or tau pathology

Science advances, 2023-05, Vol.9 (19), p.eadf3775-eadf3775

2023

Volltextzugriff (PDF)

Transmembrane domain-driven PD-1 dimers mediate T cell inhibition

Science immunology, 2024-03, Vol.9 (93), p.eade6256

2024

Volltextzugriff (PDF)

Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFL

Journal of virology, 2015-09, Vol.89 (17), p.9090-9102

2015

Volltextzugriff (PDF)

1 – 25 von 201

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(188)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(142)
Life Sciences & Biomedicine
(63)
Technology
(63)
Humans
(37)
Engineering
(32)
Physical Sciences
(28)
Animals
(21)
Materials Science
(21)
Computer Science
(17)
Materials Science, Multidisciplinary
(17)
Engineering, Electrical & Electronic
(16)
Science & Technology - Other Topics
(15)
Chemistry
(13)
Female
(13)
Hiv-1 - Immunology
(13)
Physics
(12)
Virology
(12)
Proteins
(11)
Social Sciences
(11)
Transportation
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines

Anti-tau single domain antibodies clear pathological tau and attenuate its toxicity and related functional defects

Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains

Single-domain antibody-based protein degrader for synucleinopathies

Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals

Structural Comparison of Human Anti-HIV-1 gp120 V3 Monoclonal Antibodies of the Same Gene Usage Induced by Vaccination and Chronic Infection

Single domain antibodies targeting pathological tau protein: Influence of four IgG subclasses on efficacy and toxicity

Rabbit Anti-HIV-1 Monoclonal Antibodies Raised by Immunization Can Mimic the Antigen-Binding Modes of Antibodies Derived from HIV-1-Infected Humans

Contrasting antibody responses to intrasubtype superinfection with CRF02_AG

Elicitation of broadly reactive antibodies against glycan-modulated neutralizing V3 epitopes of HIV-1 by immune complex vaccines

Efficient Huber-Markov Edge-Preserving Image Restoration

Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth

Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies

The inhibition effect of anti-GPIIIa49-66 antibody on megakaryocyte differentiation

The structural features that distinguish PD-L2 from PD-L1 emerged in placental mammals

The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel

Single domain antibody‐based non‐invasive in vivo imaging of tau pathology

VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA

The wide utility of rabbits as models of human diseases

Increased Epitope Complexity Correlated with Antibody Affinity Maturation and a Novel Binding Mode Revealed by Structures of Rabbit Antibodies against the Third Variable Loop (V3) of HIV-1 gp120

Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7

Single-domain antibody-based noninvasive in vivo imaging of α-synuclein or tau pathology

Transmembrane domain-driven PD-1 dimers mediate T cell inhibition

Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to [alpha].sub.4[beta].sub.7

Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFL

Suchergebnisse filtern